Ixaltis Overview
- Founded
-
2012
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
2ndary - Private
- Investors
-
7
Ixaltis General Information
Description
Developer of novel pharmaceutical products designed to treat disorders of the urogenital tract. The company's products include selective serotonin, reuptake inhibitor and mixed serotonin agonist-antagonist, enabling patients to improve urinary continence.
Contact Information
Website
www.ixaltis.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
- Canal Biotech 2
- 3, rue des satellites
- 31400 Toulouse
- France
+33 04 00 00 00 00
Ixaltis Timeline
Ixaltis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 01-Mar-2021 | 000.00 | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series A) | 27-Jul-2018 | 00.000 | 000.00 | 0000 | Completed | Generating Revenue |
| 2. Early Stage VC | 27-May-2016 | $9.1M | $12.2M | Completed | Generating Revenue | |
| 1. Debt - General | $3.16M | $3.16M | Completed | Startup |
Ixaltis Executive Team (5)
Ixaltis Board Members (10)
| Name | Representing | Role | Since |
|---|---|---|---|
| Benedikt Timmerman Ph.D | Self | Board Member | 000 0000 |
| Christian Chavy | Ixaltis | Chairman | 000 0000 |
| Hasnaa Hafid | iXO Private Equity | Board Observer | 000 0000 |
| Jean-Briac Lesne | Sofimac Innovation | Board Member | 000 0000 |
| Mario Caria | Sofimac Investment Managers | Board Member | 000 0000 |
Ixaltis Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Ixaltis Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Emergence (Incubation) | Asset Manager | Minority | 000 0000 | 000000 0 | |
| UROsphere | Corporation | Minority | 000 0000 | 000000 0 | |
| iXO Private Equity | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Pierre Goineau | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| Sofimac Innovation | Venture Capital | Minority | 000 0000 | 000000 0 |
Ixaltis Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 (00000 | 30-May-2016 | 000000000 | Buildings and Property | 0000000 0 |